Former chief scientist takes reins at IVA

By
January 4, 2007 22:26

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Orna Berry, a partner at Gemini Israel Funds who previously held the position of chief scientist at the Ministry of Industry, Trade and Labor, was named chairman of the Israel Venture Association on Thursday. Berry, who succeeds Yoram Oron in the position, also co-founded ORNET Data Communication Technologies helping to drive the company's growth until it was acquired by technology giant Siemens. Outlining the IVA's plans for the coming year, Berry told The Jerusalem Post key issues for the group would be to discover relationships with entrepreneurs and the evolution of young venture capitalists into the larger community as international activity would focus on the professional market segment, limited partners and institutional investors. Locally, she added, the IVA would work with institutional investors to augment social and educational activities with the Israeli community. "My intention is to continue the effort to ensure that the VC market remains the main engine for economic growth in Israel," she said. A.K.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS